CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Total Rithm Capital Stockholders’ Equity	Preferred Stock	Preferred Stock Preferred Stock	Common Stock	Common Stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021			52,210,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021					466,758,266
Equity, beginning balance at Dec. 31, 2021	$ 6,669,380	$ 6,604,032	$ 1,262,481		$ 4,669		$ 6,059,671	$ (813,042)	$ 90,253	$ 65,348
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(470,413)	(470,413)						(470,413)
Dividends declared on preferred stock	(89,726)	(89,726)						(89,726)
Capital distributions	(27,047)									(27,047)
Repurchases of preferred stock (in shares)				(245,878)
Repurchases of preferred stock	(5,227)	(5,227)		$ (5,227)
Cashless exercise of 2020 Warrants (in shares)						6,858,347
Cashless exercise of 2020 Warrants						$ 69	(69)
Director share grants and stock-based compensation (in shares)					98,487
Director share grants and stock-based compensation	2,418	2,418			$ 1		2,417
Comprehensive Income:
Net income	983,285	954,519						954,519		28,766
Unrealized gain on available-for-sale securities, net	(52,602)	(52,602)							(52,602)
Cumulative translation adjustment, net	0
Total comprehensive income	930,683	901,917								28,766
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2022			51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2022					473,715,100
Equity, ending balance at Dec. 31, 2022	7,010,068	6,943,001	$ 1,257,254		$ 4,739		6,062,019	(418,662)	37,651	67,067
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(483,192)	(483,192)						(483,192)
Dividends declared on preferred stock	(89,579)	(89,579)						(89,579)
Capital contributions	4,733									4,733
Capital distributions	(21,994)									(21,994)
Cashless exercise of 2020 Warrants (in shares)					9,287,347
Cashless exercise of 2020 Warrants	0				$ 93		(93)
Purchase of non-controlling interest	35,873									35,873
Director share grants and stock-based compensation (in shares)					223,792
Director share grants and stock-based compensation	8,432	8,432			$ 1		12,396	(3,965)
Comprehensive Income:
Net income	630,674	622,257						622,257		8,417
Unrealized gain on available-for-sale securities, net	5,437	5,437							5,437
Cumulative translation adjustment, net	586	586							586
Total comprehensive income	$ 636,697	628,280								8,417
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2023			51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2023	483,226,239				483,226,239
Equity, ending balance at Dec. 31, 2023	$ 7,101,038	7,006,942	$ 1,257,254		$ 4,833		6,074,322	(373,141)	43,674	94,096
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(503,399)	(503,399)						(503,399)
Dividends declared on preferred stock	(96,456)	(96,456)						(96,456)
Capital contributions	42,627									42,627
Capital distributions	(29,334)									(29,334)
Issuance of common stock (in shares)					36,097,793
Issuance of common stock	$ 409,957	409,957			$ 360		409,597
Option exercise (in shares)	7,050,335				917,745
Option exercise					$ 9		(9)
Purchase of non-controlling interest	$ (26,042)									(26,042)
Director share grants and stock-based compensation (in shares)					414,479
Director share grants and stock-based compensation	39,215	39,215			$ 4		44,703	(5,492)
Comprehensive Income:
Net income	941,492	931,503						931,503		9,989
Unrealized gain on available-for-sale securities, net	8,885	8,885							8,885
Cumulative translation adjustment, net	(1,673)	(1,673)							(1,673)
Total comprehensive income	$ 948,704	938,715								9,989
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2024	51,964,122		51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2024	520,656,256				520,656,256
Equity, ending balance at Dec. 31, 2024	$ 7,886,310	$ 7,794,974	$ 1,257,254		$ 5,206		$ 6,528,613	$ (46,985)	$ 50,886	$ 91,336